Co-Authors
This is a "connection" page, showing publications co-authored by Jan Cerny and Kamal Sahu.
Connection Strength
9.421
-
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside. Lab Med. 2021 Jan 04; 52(1):24-35.
Score: 0.922
-
Challenges of Cellular Therapy During the COVID-19 Pandemic. Adv Exp Med Biol. 2021; 1318:657-672.
Score: 0.922
-
A review on how to do hematology consults during COVID-19 pandemic. Blood Rev. 2021 05; 47:100777.
Score: 0.912
-
COVID-19 related immune hemolysis and thrombocytopenia. J Med Virol. 2021 02; 93(2):1164-1170.
Score: 0.898
-
Managing patients with hematological malignancies during COVID-19 pandemic. Expert Rev Hematol. 2020 08; 13(8):787-793.
Score: 0.892
-
Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. 2020 11; 92(11):2277-2282.
Score: 0.892
-
"Because Every Drop Counts": Blood donation during the COVID-19 Pandemic. Transfus Clin Biol. 2020 08; 27(3):105-108.
Score: 0.892
-
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020 07; 190(2):e86-e89.
Score: 0.887
-
COVID-19 pandemic and impact on hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 11; 55(11):2193-2195.
Score: 0.880
-
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians. Blood Cells Mol Dis. 2020 07; 83:102439.
Score: 0.876
-
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19. J Thromb Thrombolysis. 2021 Apr; 51(3):657-662.
Score: 0.227
-
Convalescent plasma therapy: A passive therapy for an aggressive COVID-19. J Med Virol. 2020 11; 92(11):2251-2253.
Score: 0.222